Announcements Trials
Browse Landscape

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 40Observational 5

Sponsor

Cancer Type

Dermatologic 5

Conditions

Keratosis, Actinic 5

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 59Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Bevacizumab 40Reverse Transcriptase Polymerase Chain Reaction 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Hepatectomy 25Therapeutics 24Neoadjuvant Therapy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Observational × 3-ingenyl angelate × Clear all
NCT04202445 2023-06-09

MIKADO

LEO Pharma

Completed
1,218 enrolled
Dermatologic

Keratosis, Actinic

NCT02090465 2019-12-17

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

LEO Pharma

Completed
840 enrolled
Dermatologic

Keratosis, Actinic

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT02421471 2019-12-13

PMS to Evaluate the Safety and Efficacy of Picato® Gel

LEO Pharma

Completed
1,324 enrolled
Dermatologic

Keratosis, Actinic

NCT02594436 2019-01-22

PrAKtice

LEO Pharma

Completed
440 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡